Free Trial
NASDAQ:TFFP

TFF Pharmaceuticals (TFFP) Stock Price, News & Analysis

TFF Pharmaceuticals logo
$0.06 0.00 (0.00%)
As of 04/10/2025

About TFF Pharmaceuticals Stock (NASDAQ:TFFP)

Key Stats

Today's Range
$0.07
$0.07
50-Day Range
$0.07
$0.07
52-Week Range
$0.06
$3.23
Volume
N/A
Average Volume
941,410 shs
Market Capitalization
$288.60 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TFFP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TFF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

TFFP Stock News Headlines

TFF Pharmaceuticals approves dissolution plan
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
TFF Pharmaceuticals Shares Fall 66%; Company to Wind Down
TFF Pharmaceuticals terminates employees, to wind down operations
TFF Pharmaceuticals to Dissolve and Liquidate Assets
TFF Pharmaceuticals Announces It Will Wind Down Operations
See More Headlines

TFFP Stock Analysis - Frequently Asked Questions

TFF Pharmaceuticals' stock was trading at $0.0650 at the start of the year. Since then, TFFP shares have increased by 0.0% and is now trading at $0.0650.

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) announced its quarterly earnings results on Wednesday, November, 20th. The company reported ($0.81) earnings per share for the quarter.

Shares of TFF Pharmaceuticals reverse split on the morning of Tuesday, December 19th 2023.The 1-25 reverse split was announced on Tuesday, December 19th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

TFF Pharmaceuticals (TFFP) raised $22 million in an initial public offering (IPO) on Friday, October 25th 2019. The company issued 4,400,000 shares at a price of $5.00 per share. National Securities served as the underwriter for the IPO.

Shares of TFFP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TFF Pharmaceuticals investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), CymaBay Therapeutics (CBAY), GE Aerospace (GE), CrowdStrike (CRWD) and Adobe (ADBE).

Company Calendar

Last Earnings
11/20/2024
Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TFFP
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$730 thousand
Price / Cash Flow
N/A
Book Value
$4.04 per share
Price / Book
0.02

Miscellaneous

Free Float
4,244,000
Market Cap
$288.60 thousand
Optionable
Optionable
Beta
0.98
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:TFFP) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners